| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. | Director | Phantom Stock Units | 112,783 | $1,340,984 | $11.89 | 13 Aug 2025 | Direct |
| Clovis Oncology, Inc. | Director | Stock Option (right to buy) | 42,223 | 10 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| WBA | Walgreens Boots Alliance, Inc. | 13 Aug 2025 | 1 | +$200,000 | 4 | Director | 15 Aug 2025, 18:15 |
| WBA | Walgreens Boots Alliance, Inc. | 01 Nov 2024 | 1 | +$200,000 | 4 | Director | 05 Nov 2024, 20:41 |
| WBA | Walgreens Boots Alliance, Inc. | 01 Nov 2023 | 1 | +$166,667 | 4 | Director | 03 Nov 2023, 19:00 |
| WBA | Walgreens Boots Alliance, Inc. | 01 Nov 2022 | 1 | +$200,000 | 4 | Director | 03 Nov 2022, 19:19 |
| WBA | Walgreens Boots Alliance, Inc. | 01 Nov 2021 | 1 | +$200,000 | 4 | Director | 03 Nov 2021, 20:12 |
| /report/000089924321023403-graham-ginger-l-2021-06-10 | Clovis Oncology, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 20:54 |